QNRX
Quoin Pharmaceuticals, Ltd.
NASDAQ · Healthcare · Biotechnology · US
$3.98
+2.05%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.61
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.90
- EPS estimate
- -$1.83
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -34.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $17
- PT range
- $14 – $20
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.83 | -$1.90 | Miss -3.83% | — |
| May 7, 2026 | -$1.80 | -$1.77 | Beat 1.67% | — |
| Mar 26, 2026 | -$6.42 | -$15 | Miss -130.53% | — |
| Nov 6, 2025 | -$6.36 | -$6.71 | Miss -5.50% | — |
| Aug 7, 2025 | -$6.83 | -$6.28 | Beat 8.05% | — |
| Mar 13, 2025 | -$0.50 | -$12 | Miss -2348.00% | — |
| Nov 7, 2024 | -$15 | -$16 | Miss -6.83% | — |
| Aug 8, 2024 | -$26 | -$14 | Beat 47.98% | — |
| May 9, 2024 | -$0.76 | -$39 | Miss -5006.58% | — |
| Mar 13, 2024 | -$83 | -$73 | Beat 12.24% | $154.8K |
| Aug 2, 2023 | -$2.82 | -$74 | Miss -2541.13% | — |
| Mar 8, 2023 | $0.62 | -$172 | Miss -27858.06% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026